Astrana Health (ASTH) Net Cash Flow (2010 - 2026)

Astrana Health has disclosed Net Cash Flow across 17 years of filings, most recently posting $49.3 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $49.3 million, up 264.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $224.1 million (up 393.84% YoY), and the FY2025 annual result was $144.9 million, up 2969.61% from the prior year.
• Net Cash Flow came in at $49.3 million for Q1 2026 at Astrana Health, up from -$30.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $124.0 million in Q3 2025 to a low of -$59.5 million in Q4 2024.
• The 5-year median for Net Cash Flow is $4.8 million (2022), against an average of $14.7 million.
• Across the five-year window, Net Cash Flow plunged 399.7% in 2024 and jumped 955.93% in 2025, its largest moves.
• Astrana Health's Net Cash Flow stood at $104.0 million in 2022, then slumped by 80.9% to $19.9 million in 2023, then tumbled by 399.7% to -$59.5 million in 2024, then jumped by 49.14% to -$30.3 million in 2025, then surged by 262.66% to $49.3 million in 2026.
• The last three Net Cash Flow figures came in at $49.3 million (Q1 2026), -$30.3 million (Q4 2025), and $124.0 million (Q3 2025), per Business Quant data.